Canafenib price 2024
Canafenib, also known asBraftovi, is a highly effective oral small molecule BRAF kinase inhibitor specifically designed to treat cancers with specific genetic mutations. Specifically, it targets unresectable or metastatic melanoma harboring the BRAF V600E or V600K mutation, as well as metastatic colorectal cancer harboring the BRAF V600E mutation.
The therapeutic mechanism of canafenib is to precisely inhibit the activity of mutated BRAF kinase and block abnormal signaling pathways, thereby effectively controlling the growth and spread of tumor cells. In clinical practice, the combined use of canafenib with other drugs, such as the MEK inhibitor bimetinib, has been proven to significantly improve treatment effects, inhibit tumor growth, and improve patient survival rates.

In terms of medication, the recommended dose of canafenib is 450 mg once daily.It can be used in combination with other kinase inhibitors such as bimetinib. However, as a powerful drug, it may also bring some side effects, common ones include fatigue, rash, nausea, diarrhea, etc. Although most of these symptoms are controllable, patients should receive a thorough medical evaluation before use and take medications strictly as directed.
Currently , as ofthe first half of 2024, canafenib has not yet been launched in China, and domestic patients cannot directly obtain this drug for the time being. It is understood that the drug has been launched in Europe, and the price of 75mg and 42 pills is about 17,000 yuan, and the price of 75mg and 168 pills is about 59,000 yuan. If the patient requires canafenib, please consult a regular overseas medical consultation service organization for more information.
The emergence of canafenib provides new treatment strategies for cancer patients with specific genetic mutations. With the deepening of medical research and progress in drug development, canafenib is expected to become an effective treatment option for more cancer patients, helping them prolong their survival and improve their quality of life.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)